NCT06102434View on ClinicalTrials.gov

Safety Profile of Psilocybin for Cocaine Use Disorder

EARLY_PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

December 31, 2025

Primary Completion Date

May 31, 2026

Study Completion Date

June 30, 2026

Conditions
Cocaine Use Disorder
Interventions
DRUG

Psilocybin

Five oral capsules containing 5 mg of psilocybin each

Trial Locations (1)

90095

University of California, Los Angeles, Los Angeles

All Listed Sponsors
lead

University of California, Los Angeles

OTHER

NCT06102434 - Safety Profile of Psilocybin for Cocaine Use Disorder | Biotech Hunter | Biotech Hunter